INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,651,000 | -16.0% | 722,882 | +7.7% | 0.00% | 0.0% |
Q3 2016 | $7,916,000 | -5.1% | 671,449 | +4.1% | 0.00% | 0.0% |
Q2 2016 | $8,345,000 | -11.3% | 644,914 | +9.6% | 0.00% | -50.0% |
Q1 2016 | $9,409,000 | -41.7% | 588,430 | +4.4% | 0.00% | -33.3% |
Q4 2015 | $16,134,000 | +2.2% | 563,541 | +1.6% | 0.00% | 0.0% |
Q3 2015 | $15,784,000 | -31.4% | 554,619 | -13.4% | 0.00% | -25.0% |
Q2 2015 | $23,010,000 | +22.8% | 640,600 | +98.7% | 0.00% | +33.3% |
Q1 2015 | $18,737,000 | +36.2% | 322,329 | -1.2% | 0.00% | +50.0% |
Q4 2014 | $13,753,000 | -1.8% | 326,220 | -9.6% | 0.00% | 0.0% |
Q3 2014 | $14,000,000 | +31.8% | 361,002 | +6.1% | 0.00% | 0.0% |
Q2 2014 | $10,624,000 | +0.8% | 340,170 | +33.7% | 0.00% | 0.0% |
Q1 2014 | $10,540,000 | +57.2% | 254,408 | +46.9% | 0.00% | +100.0% |
Q4 2013 | $6,706,000 | +48.8% | 173,234 | +34.5% | 0.00% | 0.0% |
Q3 2013 | $4,507,000 | +421.0% | 128,807 | +106.1% | 0.00% | – |
Q2 2013 | $865,000 | – | 62,483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |